Eleonora M. De Leede
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.
Journal: PloS one
Published: April 05, 2021
Torsion of a mucocele of the veriform appendix: report of a case.
Journal: Journal of surgical case reports
Published: September 17, 2020
Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
Journal: Annals of surgical oncology
Published: February 09, 2020
Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial.
Journal: Cardiovascular and interventional radiology
Published: October 20, 2018
Erratum to: Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.
Journal: Cardiovascular and interventional radiology
Published: August 26, 2017
Multicentre randomized clinical trial of the effect of chewing gum after abdominal surgery.
Journal: The British journal of surgery
Published: June 13, 2017
Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.
Journal: Cardiovascular and interventional radiology
Published: December 07, 2016
Isolated (hypoxic) hepatic perfusion with high-dose chemotherapy in patients with unresectable liver metastases of uveal melanoma: results from two experienced centres.
Journal: Melanoma research
Published: August 12, 2016
Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver.
Journal: Journal of visualized experiments : JoVE
Published: August 09, 2016
Common variables in European pancreatic cancer registries: The introduction of the EURECCA pancreatic cancer project.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: September 07, 2015
Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies.
Journal: Cardiovascular and interventional radiology
Published: September 05, 2015
Last Updated: 09/26/2026